Induction of HLA-A2-Restricted CTLs to the Mucin 1 Human Breast Cancer Antigen

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5211-5218

  Apostolopoulos, Vasso ^a   Karanikas, Vaios ^a   Haurum, John S ^b   McKenzie, Ian F C ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN; EPITOPE; HLA A2 ANTIGEN; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTATION; ARTICLE; BREAST TUMOR; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; TRANSGENIC MOUSE; VARIABLE NUMBER OF TANDEM REPEAT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES; HLA-A2 ANTIGEN; HUMANS; MICE; MICE, TRANSGENIC; MINISATELLITE REPEATS; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0031297362     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Celluzzi, C. M., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and L. D. Falo. Jr. 1996. Peptide pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
2. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
3. Nohria, A., and R. H. Rubin. 1994. Cytokines as potential vaccine adjuvants. Biotherapy 7:261.
4. Apostolopoulos, V., P. X. Xing, and I. F. C. McKenzie. 1994. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens. Cancer Res. 54:5186.
5. 2 immune responses. Proc. Natl. Acad. Sci. USA 92:10128.
6. Apostolopoulos, V., B. E. Loveland, G. A. Pietersz, and I. F. C. McKenzie. 1995. CTL in mice immunized with human mucin 1 are MHC-restricted. J. Immunol. 155:5089.
7. Van der Bruggen, P., C. Travesari, P. Chomez, C. Lurquin, E. DePlaen, B. van der Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on human melanoma. Science 254:1643.
8. Celis, E., V. Tsai, C. Crimi, R. DeMars, P. A. Wentworth, R. W. Chestnut, H. M. Grey, A. Sette, and H. M. Serra. 1994. Induction of antitumor cytotoxic T-lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91:2105.
9. Coulie, P. G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Travesari, S. Mattel, E. De Plaen, C. Lurquin, J. P. Szikora, J. C. Renauld, and T. Boon. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T-lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35.
10. Disis, M. L., J. W. Smith, A. E. Murphy, W. Chen, and M. A. Cheever. 1994. In vitro generation of human CTL specific for peptides derived from the Her-2/neu protooncogene protein. Cancer Res. 54:1071.
11. Kawakami, Y., S. Eliyaha, C. H. Delgado, P. F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human-melanoma antigen recognized by autologous T-cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91:3515.
12. Theobald, M., J. Biggs, D. Dittmer, A. J. Levine, and L. A. Sherman. 1995. Targeting p53 as a general tumor antigen. Proc. Natl. Acad. Sci. USA 92:11993.
13. Apostolopoulos, V., and I. F. C. McKenzie. 1994. Cellular mucins: targets for immunotherapy. Crit. Rev. Immunol. 14:293.
14. Apostolopoulos, V., J. Haurum, and I. F. C. McKenzie. 1997. MUC1 peptide epitopes associated with 5 different H2 class I molecules. Eur. J. Immunol. In press.
15. Domenech, N., R. A. Henderson, and O. J. Finn. 1995. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. J. Immunol. 155:4766.
16. Apostolopoulos, V., P. X. Xing, J. A. Trapani, and I. F. C. McKenzie. 1993. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein. Br. J. Cancer 67:713.
17. Apostolopoulos, V., G. A. Pietersz, and I. F. C. McKenzie. 1996. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine 14:930.
18. Xing, P. X., J. Prenzoska, K. Quelch, and I. F. C. McKenzie. 1992. Second generation anti-MUC1 peptide monoclonal antibodies. Cancer Res. 52:2310.
19. Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, and R. W. Chestnut. 1991. Analysis of the HLA-restricted influenza-specific CTL response in transgenic mice carrying a chimeric human-mouse class 1 MHC molecule. J. Exp. Med. 173:1007.
20. Elvin, J., C. Potter, T. Elliot, V. Cerundolo, and A. Townsend. 1993. A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity. J. Immunol. Methods 138:161.
21. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
22. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693.
23. Shirai, M., T. Arichi, M. Nishioka, T. Nomura, K. Ikeda, K. Kawanishi, V. H. Engelhard, S. M. Feinstone, and J. A. Berzovsky. 1995. CTL responses to HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J. Immunol. 154:2733.
24. Epstein, H., J. S. Hardy, M. H. May, M. H. Johnson, and N. Holmes. 1989. Expression and function of HLA-A2.1 in transgenic mice. Eur. J. Immunol. 19: 1575.
25. Le, A. T., E. J. Bernhard, M. J. Holterman, S. Strub, P. Parham, E. Lacy, and V. H. Engelhard. 1989. Cytotoxic T cell responses in HLA-A2.1 transgenic mice: recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J. Immunol. 142:1366.
26. Irwin, M. J., W. R. Heath, and L. A. Sherman. 1989. Species restricted interactions between CD8 and the α-3 domain of class I influence the magnitude of the xenogeneic response. J. Exp. Med. 170:1091.
27. Ressing, M. E., A. Sette, R. M. P. Brandt, P. A. Wentworth, M. Hartman, C. Oseroff, H. M. Grey, C. J M. Melief, and W. M. Kast. 1995. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*-201-binding peptides. J. Immunol. 154:5934.
28. Dahl, A. M., P. C. Beverley, and H. J. Stauss. 1996. A synthetic peptide derived from the tumor-associated protein mdm2 can stimulate autoreactive, high avidity cytotoxic T lymphocytes that recognize naturally processed protein. J. Immunol. 157:239.
29. Fairchild, P. J., and D. C. Wraith. 1996. Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. Immunol. Today 17:80.
30. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligand and peptide motifs: first listing. Anniversary review. Immunogenetics 41:178.
31. b-restricted cytotoxic T cell epitope. J. Immunol. 155:5519.
32. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92:2479.
33. Young, A. C. M., S. G. Nathenson, and J. C. Sacchettini. 1995. Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation. FASEB J. 9:26.
34. Pecher, G., and O. J. Finn. 1996. Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells. Proc. Natl. Acad. Sci. USA 93:1699.
35. Karanikas, V., L. Hwang, J. Pearson, C. S. Ong, V. Apostolopoulos, H. Vaughan, P. X. Xing, G. Jamieson, G. A. Pietersz, B. Tait, R. Broadbent, G. Thyme, and I. F. C. McKenzie. 1997. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J. Clin. Invest. In press.